Starlight Therapeutics is developing STAR-001, a highly potent, brain-permeable small molecule prodrug with synthetic lethality properties that targets adult and pediatric CNS tumors including glioblastoma, brain metastases, ATRT, and DIPG.
Developing direct bladder delivery platform for bladder cancer treatment.
Tennr is an agentic patient orchestration platform that helps providers get the right patients into the right care settings at the right time by automating document processing, intake, benefits investigations, and clinical qualifications.